Research & Innovation
Publications
Potential to improve the therapeutic situation of HCC patients – The influence of Regorafenib and Lenvatinib treatment in combination with Cdk5 inhibition in HCC
PMU Author
Petra Huber-Cantonati
All Authors
MA Ardelt, Petra Huber-Cantonati, J. Pachmayr
Abstract
We are sorry. The full text is not available.